Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain. - Wikidata - wikimedia - TriplyDB

Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.

Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.

http://www.wikidata.org/entity/Q48744526

about

Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways Oxidized cholesterol as the driving force behind the development of Alzheimer's disease ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis Alzheimer disease models and human neuropathology: similarities and differences Apolipoprotein E: from lipid transport to neurobiology Effects of human apolipoprotein E isoforms on the amyloid beta-protein concentration and lipid composition in brain low-density membrane domains Neuronal or glial expression of human apolipoprotein e4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and triple-transgenic mice Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease.Role of ABC transporters in the pathogenesis of Alzheimer's disease Regulation of cerebral cholesterol metabolism in Alzheimer disease.Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease.Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.Dementia of the Alzheimer type.A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.Human Apolipoprotein E concentration in response to diseases and therapeutic treatments

P2860

Q26779424-E68BA25A-6163-4409-AD31-3A5299633C53 Q27023315-2CC624CB-EF4E-4BA0-AF5E-D4C7D6A34BE2 Q28504715-6B03B551-53C1-40AA-8717-DE8C63F56562 Q30499574-4872BA5C-2A2C-48B4-8ABB-C9A91855059B Q34497951-D7F4090A-11BC-471A-BA94-3AC294FC39FA Q34624644-9225CC76-3022-4723-96F0-15BFDA2E8620 Q35070741-5A47A316-210D-40EA-92C0-61B63ED071B7 Q36401406-68813415-AD04-463C-BEE3-BE4E3D2CCE8E Q36418108-2ADFA74D-E263-4E14-898B-464F506BD821 Q36841850-9D2966EC-856B-4904-B852-53CD510108A7 Q36961152-6DBBCA83-3D9C-4752-827B-5514ECFB867D Q37124428-5CAE220C-97F0-4060-AE15-8823BBA63943 Q37219298-6044DAB1-8780-4C6E-A410-34F80BE00BC3 Q37535572-AB7CB099-0AEC-412B-9A8A-73447F6C99F0 Q37979824-959444AF-16BE-43DE-B8C3-9C5F98C7B198 Q42049013-163DEE18-FC9C-4B00-9B58-A72D0DE6916C Q57995824-422B6AED-DE51-4050-8091-7FFA0A50CAD2

P2860

Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.

http://www.wikidata.org/entity/Q48744526

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Human apolipoprotein E4 accele ...... APPsw transgenic mouse brain.

@en

Human apolipoprotein E4 accele ...... APPsw transgenic mouse brain.

@nl

type

label

Human apolipoprotein E4 accele ...... APPsw transgenic mouse brain.

@en

Human apolipoprotein E4 accele ...... APPsw transgenic mouse brain.

@nl

prefLabel

Human apolipoprotein E4 accele ...... APPsw transgenic mouse brain.

@en

Human apolipoprotein E4 accele ...... APPsw transgenic mouse brain.

@nl

P1433

Q48744526-C1B6AF63-5C71-4F1B-BE73-53D188FA7FC3

P1476

Q48744526-EA3F32FD-3218-48C4-9FD3-F95BD6439283

P2093

Q48744526-36E25CEE-4644-49B6-A9F5-10B8B5E6A728

Q48744526-37771BF7-198F-470A-BFD4-6C022BAD3B5B

Q48744526-3ACBE072-DE20-484D-8B8A-071F86CFD624

Q48744526-6F7D988D-9374-4E66-ACB8-5B65E5CBCF8C

Q48744526-76D5E781-5CCC-4381-998F-A614837BB15B

Q48744526-7F489BB2-F63E-4951-9CF4-53D173476506

Q48744526-806AD042-6C63-459A-A262-11969EC57FA0

Q48744526-90471986-527A-48DF-9606-A062C5CC8CD1

Q48744526-AC317B48-C171-416A-BE89-4455FFF180FF

Q48744526-CB7188DA-2268-44C1-A643-D0AD885E035A

P2860

Q48744526-033526BF-FA85-473F-8B53-056211BABF20

Q48744526-11A28BBE-82C5-4B0D-86FD-003B14EC45A8

Q48744526-131E59FF-7A97-4EF0-AB3B-78DC2AD732CE

Q48744526-14A6AB11-C21A-42D7-AC2B-5B2377FC05DC

Q48744526-1735192F-5EAD-42AA-8BC1-CB1B5C8A4C25

Q48744526-17BA9BEE-7BF6-4E38-842C-4D54F1D7B9DF

Q48744526-1FC4F66B-DA9F-47AF-9783-DF608EE16B36

Q48744526-27D30C9F-76F0-41CA-A8DF-CD1E5A23FF95

Q48744526-2B06FDB7-1085-4A3C-BA87-D27AD52A20B5

Q48744526-3285C7C1-C7EF-4493-8E52-2110E5A6E739

P304

Q48744526-90EC8038-FB17-465E-8BAB-B58AE9B43FD3

P31

Q48744526-B7CD9F72-C141-47BE-8E81-20BA52B0F23C

P356

Q48744526-5C3E2439-54F4-4D0C-BDC4-76A177E47A27

P433

Q48744526-72A204C6-1FBC-40DC-ADA2-CF31C94BC8D1

P478

Q48744526-1E8566DF-C985-4F77-859E-674AEA5D79B7

P577

Q48744526-A22824AD-3659-4E4E-95C0-4C100770FFDE

P698

Q48744526-8333F7DA-5F8F-41A2-AF95-C70BD0FC6C5E

P356

P1433

Annals of Neurology

P1476

Human apolipoprotein E4 accele ...... APPsw transgenic mouse brain.

@en

P2093

Boller JA

http://www.w3.org/2001/XMLSchema#string

Boyle TP

http://www.w3.org/2001/XMLSchema#string

Carter DB

http://www.w3.org/2001/XMLSchema#string

Dunn E

http://www.w3.org/2001/XMLSchema#string

Gurney ME

http://www.w3.org/2001/XMLSchema#string

Kuiper SL

http://www.w3.org/2001/XMLSchema#string

McKinley DD

http://www.w3.org/2001/XMLSchema#string

Oostveen JA

http://www.w3.org/2001/XMLSchema#string

Stratman NC

http://www.w3.org/2001/XMLSchema#string

Weaver RJ

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Apolipoprotein E and Alzheimer disease

Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

Discovery of a brain promoter from the human transferrin gene and its utilization for development of transgenic mice that express human apolipoprotein E alleles.

Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases.

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

P304

468-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.1134

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11601499

http://www.w3.org/2001/XMLSchema#string